Stock action on Monday spanned the market-cap spectrum, with several high-profile names retreating and a range of technology, semiconductor, energy and biotech companies posting advances. The day featured analyst initiations and ratings changes, product introductions, partnership announcements and acquisition news that correlated with price moves across mega-cap, large-cap, mid-cap and small-cap groups.
Mega-cap movers (Market Cap: $200 billion and higher)
- SpaceX (SPCX) - KeyBanc initiated coverage of SpaceX with a Sector Weight rating; the stock fell -9.87%.
- Google Inc (GOOGL) - the stock declined -5.22%.
- Arm (ARM) - the stock slipped -4.73%.
- Micron Tech (MU) - Micron announced a partnership with Anthropic on AI infrastructure and a supply deal; the stock rose +4.72%.
- AbbVie Inc (ABBV) - AbbVie said it will acquire Apogee Therapeutics for $10.9 billion; the stock gained +4.71%.
- SanDisk Corp-Exch (SNDK) - the stock climbed +5.66%.
- Dell Inc (DELL) - Dell launched the PowerEdge XE8812 server featuring Nvidia Vera Rubin; the stock increased +4.5%.
- Adv Micro Device (AMD) - the stock rose +1.06%.
- Intel Corp (INTC) - the stock advanced +3.22%.
- Seagate Technology (STX) - the stock moved up +3.79%.
Large-cap movers (Market Cap: $10-$200 billion)
- Super Micro Compu (SMCI) - Supermicro unveiled a data center blueprint for HPC and AI systems; the stock jumped +11.48%.
- Credo Technology Holding (CRDO) - Evercore ISI initiated coverage of Credo Technology with an outperform rating; the stock rose +9.44%.
- Vicor Corp (VICR) - the stock increased +8.34%.
- ON Semiconductor (ON) - the stock gained +7.81%.
- Silicon Motion Te (SIMO) - the stock climbed +5.01%.
- Coherent (COHR) - the stock added +4.88%.
- Coinbase Global (COIN) - the stock moved up +3.76%.
- Venaxis (RIOT) - the stock rose +3.45%.
- Innio Holding Gmbh (INIO) - the stock advanced +5.99%.
- Moderna (MRNA) - the stock fell -8.35%.
Mid-cap movers (Market Cap: $2-$10 billion)
- Mind Medicine Inc OTC (DFTX) - Definium is scheduled to present phase 3 depression trial results Monday; the stock gained +44.69%.
- Apogee Therapeutics (APGE) - the stock jumped +46.77%.
- Ekso Bionics Holding (CHRN) - the stock rose +20.19%.
- Marathon Pa (MARA) - the stock climbed +14.24%.
- Bitfarms OTC (KEEL) - the stock increased +13.68%.
- ARCA biopharma (ORKA) - the stock gained +13.34%.
- Fervo Energy Co Ltd (FRVO) - Fervo Energy announced a partnership with Nvidia and PNNL on a geothermal digital twin; the stock rose +13.0%.
- Kymera Therapeutics Inc (KYMR) - the stock moved up +10.75%.
- Aeglea Bio Therapeutics Inc (SYRE) - the stock added +9.38%.
- Biohaven Pharmaceutical Holding Co (BHVN) - the stock increased +14.15%.
Small-cap movers (Market Cap: $300 million - $2 billion)
- Brp Group Inc (BWIN) - JPMorgan upgraded Baldwin Insurance stock rating amid a strategic review; the stock gained +15.79%.
- Shutterstock (SSTK) - the stock climbed +16.87%.
- Freecast (CAST) - the stock fell -16.17%.
- Roth CH Acquisition V (NUAI) - the stock rose +12.64%.
- Helix Acquisition Corp (MLTX) - MoonLake reported phase 3 hidradenitis suppurativa trial results; the stock increased +13.17%.
- Regenxbio Inc (RGNX) - Regenxbio said it has aligned with the FDA on a gene therapy resubmission path; the stock rose +11.79%.
- CONL (CONL) - the stock gained +7.39%.
- East Stone Acquisition Corp (AIIO) - the stock climbed +14.26%.
- Bull Horns (ZSQR) - the stock fell -11.81%.
These moves reflect a mix of analyst coverage actions, product and partnership announcements, and corporate transactions that correlated with price action across sectors including technology, semiconductors, servers, data center infrastructure, biotech and energy. The day’s activity spanned from large strategic deals and analyst initiations at the mega-cap level to trial-related updates and partnership news among small- and mid-cap companies.
Note: This account focuses strictly on the market moves and the company statements or analyst actions linked to those moves. It does not provide trading advice.